Form 4 holding
Director
Chavant Capital Acquisition Corp.
- Security class
- Class A Common Stock
- Shares / value
- 540,966
- Estimated value
- $5,409,660
- Report date
- 21 Dec 2023
- Price
- $10.00
- Ownership
- Indirect
Andre-Jacques Auberton-Herve
Insider Reports History
- Reporting-owner location
- La Tronche, France
- Latest reporting-owner signature
-
/s/ Andre-Jacques Auberton-Herve
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Andre-Jacques Auberton-Herve
Form 4 holding
Director
Bionik Laboratories Corp.
- Security class
- Common Stock
- Shares / value
- 1,109,271
- Estimated value
- $665,563
- Report date
- 13 Jun 2023
- Price
- $0.6000
- Ownership
- Shares held through Star SCI
Form 4 holding
Director
Chavant Capital Acquisition Corp.
- Security class
- Class A Common Stock
- Shares / value
- 27,826
- Estimated value
- $278,260
- Report date
- 21 Dec 2023
- Price
- $10.00
- Ownership
- Direct
Form 4 holding
Director
Bionik Laboratories Corp.
- Security class
- Common Stock
- Shares / value
- 95,149
- Estimated value
- $57,089
- Report date
- 13 Jun 2023
- Price
- $0.6000
- Ownership
- Direct
Form 4 holding
Director
Bionik Laboratories Corp.
- Security class
- Common Stock
- Shares / value
- 10,693
- Estimated value
- $6,416
- Report date
- 13 Jun 2023
- Price
- $0.6000
- Ownership
- Shares held through 4A Consulting and Engineering
Form 4 holding
Director
Chavant Capital Acquisition Corp.
- Security class
- Make-Whole Shares (right to acquire)
- Shares / value
- 145,335
- Estimated value
- Report date
- 21 Dec 2023
- Price
- Ownership
- Indirect
- Underlying class
- Class A Common Stock
- Underlying amount
Form 4 holding
Director
Bionik Laboratories Corp.
- Security class
- Convertible Promissory Note
- Shares / value
- 1
- Estimated value
- Report date
- 13 Jun 2023
- Price
- Ownership
- Through Star SCI
- Underlying class
- Common Stock, par value $0.001 per share
- Underlying amount
Insider Reports Filed by Andre-Jacques Auberton-Herve
4
MOBX
Chavant Capital Acquisition Corp.
- Report period
- 21 Dec 2023
- Transactions
- 3
- Transaction value
- +$1,453,350
- Accepted by SEC
- 26 Dec 2023, 17:56
- Role
- Director
- Next action
- Open filing details
4
Bionik Laboratories Corp.
- Report period
- 13 Jun 2023
- Transactions
- 2
- Transaction value
- +$331,667
- Accepted by SEC
- 21 Jun 2023, 10:58
- Role
- Director
- Next action
- Open filing details
4
Bionik Laboratories Corp.
- Report period
- 09 Jun 2023
- Transactions
- 1
- Transaction value
- +$390,000
- Accepted by SEC
- 21 Jun 2023, 10:55
- Role
- Director
- Next action
- Open filing details
4
MOBX
Chavant Capital Acquisition Corp.
- Report period
- 24 Feb 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 28 Feb 2022, 10:38
- Role
- Director
- Next action
- Open filing details
3
MOBX
Chavant Capital Acquisition Corp.
- Report period
- 19 Jul 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 20 Jul 2021, 18:19
- Role
- Director
- Next action
- Open filing details
4
Bionik Laboratories Corp.
- Report period
- 15 Jul 2021
- Transactions
- 4
- Transaction value
- +$210,201
- Accepted by SEC
- 21 Jun 2022, 17:49
- Role
- Director
- Next action
- Open filing details